The World Health Organization (WHO) on November 26 classified the B.1.1.529 variant detected in South Africa as a SARS-CoV-2 “variant of concern,” saying it may spread more quickly than other forms.
If you are not happy with the results below please do another search
50 search results for:
AstraZeneca is examining the impact of a new coronavirus variant that is spreading rapidly in South Africa on the company’s vaccine and antibody cocktail, and is hopeful that the combination drug would retain efficacy.
Top U.S. infectious disease official Dr. Anthony Fauci said on November 26 that a ban on flights from southern Africa was a possibility and the United States was rushing to gather data on the new COVID-19 variant.
Britain said on November 26 that a newly identified coronavirus variant spreading in South Africa was of huge concern, and considered by scientists to be the most significant one yet found as it could make vaccines less effective.
Millions of Americans got COVID-19 booster shots at a near record pace after the Biden administration expanded eligibility last week, but health officials concerned about climbing infections ahead of the winter holiday season urged more to get the additional protection.
With the Thanksgiving holiday upon us, BioSpace felt it was important to give thanks for some of the positive things that have happened during 2021. And there are many! The accomplishments, opportunities and possibilities the scientific community has brought to bear, providing a way out of the COVID-19 pandemic and hope for the future of meaningful therapies for several challenging diseases, deserve a major shout-out.
New Covid-19 cases jumped 23% in the Americas in the last week, mostly in North America where both the United States and Canada are reporting increasing infection rates, the Pan American Health Organization (PAHO) said on November 24, warning that the region might be facing a relapse as in Europe.
Coronavirus infections broke records in parts of Europe on November 24, with the continent once again the epicenter of a pandemic that has prompted new curbs on movement and made health experts think again about booster vaccination shots.
Shares of Kura Oncology plunged in trading on November 24 after the San Diego-based company announced the U.S. Food and Drug Administration placed a partial clinical hold on a Phase Ib leukemia study assessing KO-539 following the report of a patient’s death.
A cardiovascular drug Pfizer licensed from Akcea Therapeutics in 2019 hit the mark in a Phase IIb dose-ranging study in patients with elevated non-HDL-C and triglycerides.